-
too much estrogen
HTN, melasma, nausea
-
too little estrogen
early/mid-cycle breakthrough bleeding, increased spotting, hypomenorrhea
-
too much progestin
fatigue, changes in mood
-
too little progestin
late breakthrough bleeding
-
most potent progestin
desogestrel, levonorgestrel, norgestrel
-
least potent progestin
norgestimate
-
most androgenic progestin
norgestrel
-
least androgenic progestin
desogestrel, norgestimate
-
anti-androgenic progestin
drospirenone
-
only four-phasic pill
Natazia (estradiol valerate + dienogest)
-
365 day a year pill
Lybrel (ethinyl estradiol + levonorgestrel)
-
oxytocin (Pitocin) interaction
simpathomimetics (increased risk of severe HTN)
-
oxytocin BBW/caution
not for elective labor induction. hypotension c rapid infusion.
-
reproductive prostaglandins (PGE1, PGE2, PGF2a)
misoprostol (Cytotec), dinoprostone (Hemabate), carboprost
-
reproductive prostaglandins indications (PGE1/PGE2; PGF2a)
labor induction and cervical ripening; postpartum hemorrhage (not first line)
-
reproductive prostaglandins BBW/contraindications
not for pregnant pts (abortion), women of child-bearing potential. contraindicated c severe asthma, glaucoma, MI.
-
antitussives: centrally acting
dextromethorphan, codeine (Cheratussin AC), hydrocodone
-
antitussives: peripherally acting
camphor, menthol, benzonatate (Tessalon)
-
-
dextromethorphan interaction
dextromethorphan + MAOI (seritonin storm)
-
benzonatate BBW
severe hypersensitivity rxns (bronchospasm, laryngospasm, CV collapse) possibly related to local anesthesia from sucking/chewing capsule instead of swallowing it
-
-
decongestants: direct alpha-1 agonists (work best topically)
phenylephrine, oxymetazolone (opthalmic Visine), naphazoline (opthalmic Naphcon/Visine A)
-
decongestants: indirect alpha-1 agonists (work best orally)
pseudoephedrine, ephedrine
-
decongestant interactions
decongestant + MAOI (hypertensive crisis)
-
rebound congestion
Rhinitis Medicamentosa
-
H1 antagonists: first gen
chlorpheniramine, brompheniramine, cyproheptadine, clemastine
-
H1 antagonists: second gen
loratadine (Claritin), cetirizine (Zyrtec), fexofenadine (Allegra)
-
fexofenadine dosing
Allegra: 60mg PO BID or 180mg PO qd
-
Cherratussin AC dosing
codeine/guaifenesin 10/100/5mL, 10-20mg codeine (1-2 tsp) PO q4-6h PRN
-
dual antihistamine/mast cell stabilizer
epinastine (Elestat)
-
Mast Cell Stabilizers
cromolyn. opthalmic nedocromil and lodoxamide.
-
Opthalmic Prostaglandins
latanoprost (Xalatan), travoprost (Travatan), bimatoprost (Lumigan)
-
Opthalmic Prostaglandins MOA
increase intraocular outflow via uveoscleral route (not Schlemm's canal)
-
latanoprost dosing
Xalatan, 1ggt in eye(s) qpm
-
Aptamers
pegaptanib (Macugen)
-
pegaptanib MOA
Macugen: binds to vascular endothelial growth factor, inhibiting the proliferation of blood vessels and reducing blood vessel permeability/leakage
-
pegaptanib dosing
injected directly into the eye!
-
Topical Corticosteroids super-high
super-high: clobetasol (Temovate) 0.05%
-
Topical Corticosteroids high
high: fluocinonide (Lidex) 0.05%
-
Topical Corticosteroids medium
medium: triamcinolone acetonide (Kenalog) 0.1%
-
Topical Corticosteroids low
low: fluocinolone acetonide 0.01%, desonide 0.05%, hydrocortisone 1%
-
Benzoyl peroxide MOA
both antibacterial and comedolytic properties. penetrates the stratum corneum or follicular openings where it is converted to benzoic acid.
-
Benzamycin
benzoyl peroxide + erythromycin
-
BenzaClin
benzoyl peroxide + clindamycin
-
Epiduo
benzoyl peroxide + adapalene
-
Benzoyl peroxide c oral antibiotics (TCAs)
combo helps prevent antibiotic resistance. No go in pregnancy.
-
Azelaic acid brand
gel form = Finacea, cream - Azelex
-
Topical Antifungals: both candida/dermatophytes
imidazoles (fungastatic) ("azoles")
-
Topical Antifungals: dermatophytes only
allylamines and benzylamines (fungicidal) ("afines")
-
Topical Antifungals: candida only
polyenes (fungistatic) (nystatin)
-
Topical Vitamin D analogs
calcipotriene, calcitriol
-
Topical Vitamin D MOA
inhibit keratinocyte proliferation
-
Taclonex
calcipotriene/betamethason (Vitamin D analog/anti-immune)
-
Keratolytics
salicylic acid, lactic acid, urea
-
imiquimod MOA
modifies immune response to skin (increases inflammation in dermis -> eradication of abnormal cells)
-
imiquimod indications
actinic keratoses, basal cell carcinoma, genital/perianal warts
-
imiquimod dosing
16 wks max (6 wks for BCC)
|
|
